EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prospects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review

Timur B. Minasov, Irina V. Sarvilina, Olga A. Gromova, Anton G. Nazarenko, Nikolay V. Zagorodniy, Ekaterina R. Yakupova, Stanislav Yu. Glazunov, Rakhimbay Dzh. Kabirov, Elmira I. Nezhemedinova

N.N. Priorov Journal of Traumatology and Orthopedics · 10.02.2026 · 33 (1) · 202-219

DOI: 10.17816/vto701936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift N.N. Priorov Journal of Traumatology and Orthopedics, online erschienen am 10.02.2026. Verfasst von Timur B. Minasov und 8 weiteren Autor:innen. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review addresses practical issues of rational pharmacotherapy and adjuvant treatment of osteoarthritis before and after total knee arthroplasty (TKA). The review analyzes the mechanisms underlying complications associated with total knee arthroplasty, the role of comorbid conditions in the development of osteoarthritis and TKA-related complications, and current approaches to phenotyping and endotyping of osteoarthritis for predicting postoperative complications and selecting optimal strategies for preoperative management and postoperative rehabilitation. Particular attention is paid to the mechanisms of action of components and to the personalized selection of disease-modifying and adjuvant therapies at different stages of patient management before and after total knee arthroplasty. The review describes recommended dosing regimens, maximum daily doses, and maximum durations of use for selected structure-modifying drugs and adjuvant therapies for osteoarthritis before and after total knee arthroplasty, based on data from clinical studies and in accordance with instructions for medical use. One of the key aspects of a multimodal, staged approach to managing patients with knee osteoarthritis before and after total knee arthroplasty is the personalized selection of structure-modifying drugs and adjuvant therapies, taking into account individual patient characteristics, including age, comorbidities, and drug tolerability. Standardization of pain assessment, evaluation of biomarkers of structural modification of articular cartilage, and a personalized approach to drug selection are essential for achieving effective and safe management of patients with knee osteoarthritis undergoing total knee arthroplasty, reducing the risk of adverse drug reactions, and improving treatment satisfaction and quality of life after surgical intervention.

Zitieren

APA

Minasov, T. B., Sarvilina, I. V., Gromova, O. A., Nazarenko, A. G., Zagorodniy, N. V., Yakupova, E. R., Glazunov, S. Y., Kabirov, R. D., & Nezhemedinova, E. I. (2026). Prospects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review. N.N. Priorov Journal of Traumatology and Orthopedics, 33(1), 202-219. https://doi.org/10.17816/vto701936

Vancouver

Minasov TB, Sarvilina IV, Gromova OA, Nazarenko AG, Zagorodniy NV, Yakupova ER, et al. Prospects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review. N.N. Priorov Journal of Traumatology and Orthopedics. 2026;33(1):202-219. doi:10.17816/vto701936

BibTeX
@article{Minasov2026,
  author = {Minasov, Timur B. and Sarvilina, Irina V. and Gromova, Olga A. and Nazarenko, Anton G. and Zagorodniy, Nikolay V. and Yakupova, Ekaterina R. and Glazunov, Stanislav Yu. and Kabirov, Rakhimbay Dzh. and Nezhemedinova, Elmira I.},
  title = {Prospects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review},
  journal = {N.N. Priorov Journal of Traumatology and Orthopedics},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {202--219},
  doi = {10.17816/vto701936}
}
Kostenlos starten →